The projections come as National Cancer Institute data notes an increase in uterine cancer cases and deaths over the past 30 years.

Thanks to improved treatments and early detection, endometrial cancer survival rates have improved. Today, 95% of people who are diagnosed at an early stage will still be alive five years later.

While incidence and mortality rates for most cancer types have been on the decline in the United States, cases of uterine ...

Uterine and endometrial cancer typically have high survival rates, especially when doctors diagnose them early and they haven’t spread to other parts of your body.

Uterine cancer incidence and mortality rates are projected to increase significantly over the next three decades in the United States, with incidence-based mortality expected to be nearly three times ...

TOPLINE: A study of 162,500 patients with uterine cancer found that survival rates varied significantly by race and geographic location, with Black patients experiencing the worst survival ...

Molecular profiling could reduce both overtreatment and undertreatment of patients with high-intermediate risk endometrial ...

The DUO-E trial highlighted the addition of durvalumab and olaparib to chemotherapy for metastatic endometrial cancer, showing promising progression-free survival (PFS) and high ctDNA detection rates.

Uterine cancer is the only cancer for which survival has actually decreased over the past 40 years, the A.C.S. said. Death rates are also rising for liver cancer among women, and for cancers of ...

Overall, cancer incidence rates among women under age 50 were 82% higher than their male counterparts in 2021, up from 51% in 2002. Women aged 50-64 are also getting cancer at higher rates than men.